ASHLEY MACY: Open Payments
NPI 1184278699 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 39 payments from 16 companies in 2025. Trend: 2023 $197 · 2024 $463 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $135 |
| Amgen Inc. | 5 | $94 |
| Merck Sharp & Dohme LLC | 4 | $60 |
| Abbott Laboratories | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| United Therapeutics Corporation | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Philips North America LLC | 1 | $33 |
Products named: REPATHA, VYNDAQEL, ELIQUIS, VERQUVO, CARDIOMEMS, JARDIANCE, AMVUTTRA, Tyvaso.
Industry payments across ND — which companies pay providers there.
